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Abstract
Objective:	To	describe	utilization	of	health	services	for,	and	case	fatality	from,	abortion	
in	Mexico.
Method:	 A	 historical	 cohort	 study	 using	 a	 census	 of	 state-	level	 aggregate	 hospital	
discharge	 and	primary	 care	 clinic	data	 across	Mexico's	32	 states	 from	 January	2000	
to	 December	 2016.	 Abortive	 events	 and	 changes	 over	 time	 in	 utilization	 per	 1000	
women	aged	15–44	years,	and	case	fatality	per	100	000	abortion-	related	events	were	
described	by	year,	health	sector,	and	state.	Associations	of	location	(Mexico	City	vs	31	
other	states)	and	time	(Mexico	City	implemented	legal	abortion	services	in	2007)	with	
outcomes	were	tested	by	linear	regression,	controlling	for	secular	trends.
Results:	The	national	abortion	utilization	rate	was	6.7	per	1000	women	in	2000,	peaked	
at	7.9	in	2011,	and	plateaued	to	7.0	in	2016.	In	Mexico	City,	utilization	peaked	at	16.7	
in	2014	and	then	plateaued.	Nationwide,	the	case-	fatality	rate	declined	over	time	from	
53.7	deaths	per	100	000	events	in	2000	to	33.0	in	2016.	Case	fatality	declined	more	
rapidly	in	Mexico	City	than	in	the	other	31	states	to	12.3	in	2015.
Conclusion:	Case	 fatality	 from	abortive	events	has	decreased	across	Mexico.	Where	
abortion	became	legal,	utilization	increased	sharply	but	plateaued	afterward.
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1  | INTRODUCTION
Access	to	induced	abortion	remains	highly	restricted	in	Mexico.	In	
Mexico	City,	induced	abortion	in	the	first	trimester	was	decriminal-
ized	in	2007,	and	services	became	immediately	available	both	in	the	
public	sector	under	the	Interrupción Legal de Embarazo	(ILE)	program1 
and	in	the	private	sector.	Induced	abortion	law	is	determined	at	the	
state	level	in	Mexico.	Outside	Mexico	City,	abortion	law	varies	in	the	
other	31	states.	Access	to	induced	abortion	under	the	rape	exception	
has	been	legal	nationwide	since	2016.2	Other	exceptions,	such	as	risk	
to	a	woman's	life	(23	states)	or	health	(15	states),	or	fetal	anomalies	 
(16	states),	are	allowed	in	some	states	but	not	others.3,4
The	incidence	of	induced	abortion	is	difficult	to	measure	in	Mexico	
owing	to	legal	restrictions,	stigma,	fragmented	health	information	sys-
tems,	and	wide	availability	of	misoprostol	outside	the	formal	health	sys-
tem.5,6	Estimates	of	the	national	incidence	of	induced	abortion	combine	
expert	 opinion	with	 aggregate	 health	 system	data,7	 and	 suggest	 that	
there	are	38	induced	abortions	per	1000	women	aged	15–44	years.8
The	ILE	program	has	provided	over	200	000	first-	trimester	induced	
abortions	 since	 April	 2007,9	 but	 far	 less	 is	 known	 about	 induced	
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abortion	services	outside	Mexico	City.	However,	services	for	all	abor-
tive	events,	which	include	International	Classification	of	Disease	10th	
revision	(ICD-	10)	code	O00-	O08	(ectopic	and	molar	pregnancy,	spon-
taneous,	 incomplete	 and	 induced	 abortion),	 do	 take	 place	 in	 health	
facilities	across	Mexico.
Case	 fatality	 owing	 to	 abortive	 events	 represents	 a	 subset	 of	 the	
deaths	due	to	total	direct	obstetric	causes.10	Case	fatality	and	utilization	
are	related	by	definition.	Utilization	is	calculated	as	the	number	of	cases	
per	women	of	reproductive	age,	and	forms	the	denominator	of	case	fatal-
ity,	which	is	calculated	as	deaths	per	total	cases.11	It	is	anticipated	that	
case	fatality	will	rise	as	utilization	increases	in	situations	where	abortive	
events	are	very	unsafe,	patients	are	very	sick,	and/or	health	care	is	poor	
quality.	By	contrast,	a	decrease	in	case	fatality	would	be	expected	as	utili-
zation	increases	in	situations	where	abortions	are	“less	unsafe”,12	patient	
health	 is	 less	complicated,	access	to	services	 improves,	and/or	there	 is	
better	quality	care.	It	is	important	to	document	both	utilization	and	out-
comes	of	the	range	of	abortion	services	that	are	provided	across	the	pub-
licly	managed	health	sectors	in	Mexico	over	time	to	both	assess	policy	
impact	and	provide	evidence	to	guide	service	delivery	and	policy-	making.
The	aim	of	the	present	study	was	to	describe	utilization	of	health	
services	for	abortive	events	and	case	fatality	from	all	abortive	events	
across	the	Mexican	health	system,	as	well	as	the	relative	contribution	
of	different	sectors	of	the	public	system	to	service	provision	over	time,	
testing	for	changes	over	time	and	by	location	(Mexico	City	vs	the	rest	
of	Mexico).
2  | MATERIALS AND METHODS
The	present	 historical	 cohort	 study	used	 state-	level	 aggregate	hos-
pital	discharge	and	primary	care	clinic	data	 in	Mexico	 from	January	
1,	2000,	to	December	31,	2016.	Because	it	was	based	on	secondary	
aggregate	data,	the	study	was	deemed	non-	human	subjects	research	
by	the	Oregon	Health	&	Science	University	Institutional	Review	Board	
and	consent	was	not	needed.
Mexico	has	robust,	if	fragmented,	health	information	systems.	The	
Mexican	health	system	is	divided	into	several	institutions,	all	publicly	
managed.	 Each	 institution	 is	 vertically	 integrated	 and	 provides	 ser-
vices	and	coverage	for	distinct	populations.13	The	Ministry	of	Health	
(MoH;	 Secretaria	 de	 Salud)	 serves	 the	 most	 vulnerable	 population,	
who	are	either	unemployed,	self-	employed,	or	work	outside	the	formal	
employment	system.	The	Instituto	Mexicano	del	Seguro	Social	(IMSS)	
and	 the	 Instituto	de	Seguro	y	Servicios	Sociales	de	 los	Trabajadores	
del	Estado	(ISSSTE)	provide	services	to	the	sector	of	formal	employ-
ees.12	Major	national	health	reforms	in	2003	expanded	access	for	the	
uninsured,	 incorporating	 them	 into	 the	MoH	 services	 under	 Seguro	
Popular	 (Popular	Health	 Insurance).14	 The	 present	 analysis	 included	
the	MoH,	IMSS,	and	ISSSTE	sectors	(see	Supplementary	Table	S1	for	a	
description	of	data	sources).	Care	in	the	private	sector,	outside	health	
facilities,	and	in	emergency	departments	was	not	included.
Data	were	analyzed	from	all	abortive	events	using	 ICD	code	O00-	
O08	(ectopic	and	molar	pregnancies,	spontaneous,	unspecified	and	other	
abortions)	 plus	 ICD-	code	 Z30.3,	which	 has	 been	 used	 since	 2007	 to	
report	legal	first-	trimester	abortions	in	Mexico	City.	First-	trimester	abor-
tion	was	decriminalized	in	Mexico	City	in	2007,	but	remains	restricted	in	
the	other	31	states.	The	analysis	was	limited	to	women	aged	15–44	years;	
although	abortive	events	occur	outside	this	age	range,	this	criterion	facili-
tated	comparison	with	previously	published	data.
The	 two	 study	 outcomes	were	 utilization	 of	 health	 services	 for	
abortive	events	and	abortion	case	fatality.	Annual	utilization	rates	were	
calculated	as	the	number	of	all	abortive	events	per	1000	women	(aged	
15–44	years)	per	year.	Population	estimates	for	each	year	at	national	
and	state	levels	were	used	to	calculate	rates	(see	Supplementary	Table	
S1).	Case-	fatality	rates	were	calculated	as	the	number	of	deaths	per	
100	000	abortive	events,	using	all	deaths	attributed	to	abortive	events.	
The	two	sectors	that	serve	formal	employees	(IMSS	and	ISSSTE)	were	
grouped	together	and	compared	with	the	MoH	in	all	analyses.
Stata	version	13	(StataCorp,	College	Station,	TX,	USA)	was	used	for	all	
data	analysis.	The	annual	utilization	and	case-	fatality	rates	were	described	
over	time	and	by	location	(Mexico	City	vs	Mexico's	other	31	states).	 In	
addition,	 pooled	 (2000–2016)	 utilization	 and	 case	 fatality	 at	 the	 state	
level	(all	32	states)	were	described.	The	proportion	of	utilization	by	sector	
(MoH	hospital,	MoH	outpatient,	IMSS/ISSSTE)	were	compared	over	time.
A	 linear	 regression	 model	 was	 developed	 to	 test	 for	 changes	
in	 the	 study	outcomes	 (utilization	per	1000	women	or	deaths	per	
100	000	events)	 by	 location	 (Mexico	City	vs	 the	other	31	 states),	
and	before	and	after	implementation	of	the	ILE	program	in	Mexico	
City	in	2007.	Data	were	treated	as	panel	data:	yearly	observations	
(2000–2016)	 were	 available	 for	 every	 Mexican	 state	 including	
Mexico	 City,	 affording	 544	 state–year	 observations.	 The	 regres-
sion	 model,	 which	 was	 a	 variation	 of	 the	 standard	 difference-	in-	
difference	 model,	 included	 a	 binary	 indicator	 to	 compare	Mexico	
City	to	Mexico's	other	31	states.	The	analysis	also	included	an	inter-
action	of	continuous	time	trend	(every	year	numbered	from	1	to	17)	
and	an	indicator	for	before	and	after	implementation	of	the	ILE	pro-
gram.	The	 continuous	 (year)	 by	 binary	 (pre/post)	 interaction	 term	
tests	whether	the	slope	of	the	continuous	variable	(year)	differs	by	
the	 level	 of	 the	 binary	variable	 (pre/post).	This	 approach	 helps	 to	
control	for	secular	trends	and	identifies	any	change	in	slope	at	the	
2007	time	 point,	when	 the	 ILE	 program	was	 implemented.	 It	 is	 a	
conservative	approach	when	 the	 standard	difference-	in-	difference	
model	 cannot	 be	 used:	 in	 the	 present	 case,	 pre-	2007	 trends	 in	
Mexico	City	and	the	31	remaining	states	were	not	parallel,	violating	
a	 key	 assumption	 of	 difference-in-difference	 models.15	 Individual	
state	 fixed	 effects	 (n=32	 states)	were	 also	 included	 to	 control	 for	
unobserved	 state	 differences	 that	 do	 not	 change	 over	 time.	 A	 P 
value	of	less	than	0.05	was	considered	statistically	significant.
3  | RESULTS
In	total,	3	351	704	cases	of	abortive	outcome	were	identified	between	
2000	and	2016	among	women	aged	15–44	years.	Utilization	increased	
from	165	750	events	in	2000	to	a	maximum	of	228	650	events	in	2012,	
and	then	decreased	to	209	018	events	in	2016.	Nationwide,	the	utili-
zation	rate	was	6.7	per	1000	women	in	2000,	peaked	at	7.9	in	2011,	
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but	then	decreased	and	stabilized	at	7.0	in	2016	(Figure	1,	red	line).	In	
Mexico	City,	utilization	was	always	higher	than	the	national	mean,	start-
ing	at	8.6	in	2000	and	increasing	steadily	over	time.	After	2007	and	the	
beginning	of	abortion	services	offered	by	the	ILE	program,	the	increase	
was	much	sharper:	utilization	rates	reached	a	peak	of	16.7	in	2014,	then	
flattened	and	declined	to	14.4	in	2016	(Figure	1,	blue	line).
The	 pooled	 data	 (2000–2016)	 highlighted	 heterogeneity	 among	
the	Mexican	states	in	utilization	of	health	services	for	abortive	events.	
The	 average	 utilization	 was	 7.1	 abortions	 per	 1000	 women	 aged	
15–44	years,	but	there	was	geographic	variation:	utilization	was	as	low	
as	4.9	in	the	State	of	Mexico,	adjacent	to	Mexico	City,	but	nearly	dou-
ble	this	value	(9.9)	in	Aguascalientes.	Utilization	was	highest	in	Mexico	
City	at	12.3	per	1000	women	(Figure	2).
The	 relative	 contribution	 of	 different	 health	 sectors	 and	 differ-
ent	 levels	of	 care	 to	 abortion	 service	utilization	changed	over	time.	
Nationally,	MoH	accounted	for	45.8%	of	all	abortion-	related	services	
in	2000	and	rose	to	65.6%	in	2016,	whereas	the	contribution	of	other	
sectors	 (ISSSTE/IMSS)	 proportionally	 declined	 (data	 not	 shown).	
Primary	care	services	accounted	for	0.01%	of	services	in	Mexico	City	in	
2000,	but	increased	to	53.9%	in	2016,	largely	due	to	implementation	
of	the	MoH	first-	trimester	ILE	program	in	Mexico	City,	which	began	in	
hospital-	based	clinics	and	gradually	shifted	over	time	to	primary	care	
clinics1	(Figure	3,	top	panel).
Nationally,	the	case-	fatality	rate,	expressed	as	deaths	per	100	000	
abortive	 events	 per	 year,	 declined	 over	 time	 from	 53.7	 deaths	 per	
100	 000	 events	 in	 2000	 to	 a	 lowest	 national	mean	 of	 33.0	 in	 2016	
(Figure	4;	red	line).	Declines	in	case	fatality	occurred	both	in	Mexico	City	
and	in	Mexico's	31	states	with	restrictive	abortion	laws,	although	case	
fatality	was	 lower	 in	Mexico	City.	 In	Mexico	City	 (Figure	4,	blue	 line),	
case	fatality	was	increasing	before	the	legalization	of	abortion,	from	24.3	
deaths	per	100	000	events	in	2000	to	49.8	in	2007,	when	it	exceeded	
the	national	average;	after	the	change	in	law,	it	declined	to	a	low	of	12.3	
in	2015.	In	Mexico's	other	31	states,	the	case-	fatality	rate	declined	from	
57.9	deaths	per	100	000	events	in	2000	to	35.8	in	2016	(Figure	4,	green	
line).	However,	there	were	important	differences	among	the	states	in	the	
pooled	data	(2000–2016),	with	a	case-	fatality	rate	as	low	as	8.2	and	9.1	
in	Baja	California	Sur	and	Colima,	but	many	times	higher	in	Chiapas	and	
Guerrero	(83.9	and	96.4,	respectively;	Figure	5).
In	 the	 regression	model	 controlling	 for	 secular	 trends	 (Table	 1),	 
utilization	increased	significantly	more	in	Mexico	City	than	in	Mexico's	
other	 31	 states	 (β,	 2.33;	 95%	CI,	 1.81–2.85).	 Case	 fatality	was	 not	
F IGURE  1 Utilization	of	abortion	services	per	1000	women	
aged	15–44	y	over	time	and	by	location.	Abbreviation:	CDMX,	
Mexico	City.
F IGURE  2 Utilization	of	abortion	services	by	state	(data	are	
means	for	the	study	period).
F IGURE  3 Contribution	of	Ministry	of	Health	hospitals,	primary	
care,	and	formal	employee	(ISSSTE/IMSS,	“other”)	sectors	to	service	
provision	for	abortive	events	in	Mexico,	2000–2016.
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significantly	different	between	Mexico	City	and	the	other	states	over	
the	whole	study	period,	and	decreased	slightly	but	significantly	after	
2007	(β,	–1.01;	95%	CI,	–1.43	to	–0.60).
4  | DISCUSSION
The	present	study	found	that,	overall,	utilization	of	health	services	for	
all	types	of	abortive	event	has	increased	across	Mexico.	Utilization	per	
1000	women	increased	sharply	in	Mexico	City	after	implementation	of	
the	ILE	program	in	2007,	and	has	since	plateaued.	The	MoH	accounted	
for	an	ever-	increasing	share	of	service	provision	over	time.	Case	fatality	
(deaths	per	abortive	events)	declined	over	time	in	the	whole	country;	
the	data	indicate	that	this	decline	was	sharper	after	2007	when	the	ILE	
program	was	implemented.	Overall,	where	utilization	was	lower	(i.e.,	the	
southern	 states),	 case	 fatality	 remained	 highest.	 The	 present	 findings	
show	 that,	 even	where	 induced	abortion	was	 legally	 restricted	 (in	31	
Mexican	states	and	in	Mexico	City	until	2007),	utilization	was	still	slightly	
increasing.	 This	 supports	 and	extends	previous	 research	 covering	 the	
time	period	to	2008	(2	years	after	implementation	of	the	ILE	program).16
A	previous	estimate	of	hospitalization	for	abortive	events	(exclud-
ing	ectopic	pregnancy)	was	8.1	per	1000	women	aged	15–44	years17; 
the	 present	 value	was	 slightly	 lower	 nationally	 (7.1	 overall,	 peaking	
at	7.9	in	2011),	but	higher	in	Mexico	City.	These	updated	data	allow	
a	 follow-	up	 of	 national	 trends,	 including	 all	 types	 of	 abortive	 event	
and	all	primary	care	facilities.	The	data	also	show	that,	after	the	sharp	
increases	 in	utilization	following	 implementation	of	the	public	sector	
induced-	abortion	 program	 in	 Mexico	 City,	 utilization	 plateaued,	 as	
observed	 in	 other	 countries	 after	 abortion	 legalization.18	 It	 is	 possi-
ble	that	utilization	outside	Mexico	City	 is	 increasing	because	of	bet-
ter	access	to	legal	induced	abortion	under	the	current	exceptions	(e.g.	
rape,	health,	fetal	malformation).	However,	research	does	not	support	
this	hypothesis:	full	implementation	of	legal	exceptions	is	known	to	be	
lacking.3,4,19	Woman	may	also	have	greater	access	to	misoprostol	out-
side	facilities	and	present	for	care	to	confirm	a	safe	induced	abortion	
process:	local	evidence	suggests	that	misoprostol	is	widely	available	in	
the	country	and	in	the	capital	city,	but	the	incidence	of	use	or	women's	
knowledge	about	safe	use	is	unknown.6
The	MoH,	which	serves	the	most	vulnerable	population	in	Mexico,	
provided	the	majority	of	all	abortion-	related	services	nationally.	This	
may	reflect	either	women's	preferences	or	a	relative	lack	of	commit-
ment	by	the	IMSS	and	ISSSTE	sectors	to	providing	essential	care	for	
abortive	events.	Both	IMSS	and	ISSSTE	have	so	far	refused	to	comply	
with	the	change	in	law,	and	do	not	provide	legal	induced	abortions	in	
Mexico	City.20	More	studies	are	needed	to	understand	whether	 the	
present	findings	indicate	a	denial	of	induced	abortion	and	other	abor-
tive	event	services	in	these	sectors.
Between	2000	and	2016,	the	case-	fatality	rate	declined	from	53.7	
deaths	per	100	000	abortive	events	to	33.0.	The	decline	in	case	fatal-
ity	occurred	nationwide	but	was	steeper	in	Mexico	City,	where	case	
fatality	 decreased	 sharply	 after	 the	 decriminalization	 of	 abortion	 in	
2007.	After	controlling	for	secular	trends,	there	was	a	small	but	sig-
nificant	decline	in	case	fatality	after	2007	when	the	ILE	program	was	
implemented,	 but	 no	 association	with	Mexico	 City	 specifically.	 The	
present	data	support	previous	findings	of	a	decline	 in	abortion	case	
fatality	 in	Mexico	at	 the	national	 level,	with	heterogeneity	between	
the	most	 and	 least	marginalized	 states.15	Globally,	 case	 fatality	 due	
to	 abortion	 has	 been	 decreasing.	 The	 present	 data	 are	 in	 line	with	
the	 most	 recent	 international	 data,	 which	 show	 case-	fatality	 rates	
of	30	deaths	per	100	000	unsafe	abortions	in	the	Latin	America	and	
Caribbean	region21;	however,	the	present	case-	fatality	rates	are	based	
on	all	abortive	events,	not	estimated	unsafe	abortions,	and	therefore	
are	not	directly	comparable.
The	study	has	some	limitations.	First,	it	did	not	include	the	pri-
vate	sector,	which	probably	has	a	large	impact	on	the	calculations	of	
service	utilization	for	first-	trimester	abortion	 in	Mexico	City.22	For	
later	gestational	ages,	and	for	the	rest	of	the	country,	underrepre-
sentation	is	likely	to	be	less	significant:	for	example,	it	is	estimated	
that	 private	 health	 sector	 provides	 no	more	 than	30%	of	 delivery	
care	 overall	 in	Mexico.23	 Second,	 the	 study	 relied	 on	 ICD	 codes,	
which	may	be	affected	by	underreporting	of	abortion.	For	example,	
F IGURE  4 Case-	fatality	rate	per	1000	abortions	over	time	and	 
by	location.
F IGURE  5 Case	fatality	by	state	(data	are	means	for	the	
study	period).
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cases	coded	as	sepsis	or	hemorrhage	might	be	abortive	events	but	
not	coded	as	such.	Thus,	both	utilization	and	case	fatality	might	be	
undercoded	or	misclassified,	as	previously	reported	in	the	Mexican	
context.24	Third,	the	study	data	cannot	be	used	for	comparisons	of	
abortion	incidence,	or	overall	abortion	rates,	because	the	focus	was	
in-	facility	utilization.	However,	 the	specific	focus	of	the	study	was	
health	facilities	that	are	part	of	the	publicly	managed	sectors:	health	
services	 research,	which	 focuses	on	what	happens	 in	health	 facil-
ities,	 is	 essential	 to	 tracking	 the	 quantity	 and	quality	 of	 care	 pro-
vided	through	the	formal	health	system	and	 is	ultimately	essential	
for	holding	governments	accountable	to	their	citizens.	Fourth,	it	was	
not	possible	 to	 include	emergency	 room	data	and	 therefore	 some	
abortive	event	cases	were	missing.	However,	women	who	were	sub-
sequently	admitted	to	public	hospitals	were	included	in	the	data.
The	 strengths	of	 the	 study	 include	 triangulating	data	 sources	 to	
cover	the	majority	of	the	health	system.	The	inclusion	of	all	abortions	
via	ICD-	code	O00-	O08	and	the	additional	incorporation	of	the	Z30.3	
code	for	legal	induced	abortions	enabled	us	to	examine	the	impact	of	
changes	associated	with	the	law	and	the	successful	implementation	of	
the	ILE	program	in	Mexico	City	on	service	utilization	and	case	fatality.
With	and	without	 changes	 to	abortion	 law,	 abortion	 is	 getting	
safer	 in	Mexico.	The	present	findings	 suggest	 that	 increased	utili-
zation	and	decreasing	case	fatality	go	hand	in	hand,	even	in	legally	
restricted	 contexts.	 Where	 the	 law	 allows	 access	 to	 legal	 abor-
tion,	 utilization	 of	 services	 increases	 and	 then	 plateaus,	 and	 case	
fatality	decreases.
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